Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 2/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | JAK2 | O60674 | 11/20 | 0.40 |
| ▸ | AURKA | O14965 | 1/20 | 0.39 |
| ▸ | CDK2 | P24941 | 1/20 | 0.39 |
| ▸ | CDK9 | P50750 | 1/20 | 0.39 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.39 |
| ▸ | JAK3 | P52333 | 9/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | IKBKB | O14920 | 1/20 | 0.37 |
| ▸ | KDR | P35968 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6069753 | 0.91 | KCNH2 (0.43) | SYKKCNH2JAK2AURKACDK2 | |
| SCHEMBL6070296 | 0.88 | FLT1 (0.46) | SYKAURKACDK2CDK9AURKB | |
| SCHEMBL6070015 | 0.87 | JAK2 (0.44) | SYKKCNH2JAK2AURKACDK2 | |
| SCHEMBL6070380 | 0.87 | KDR (0.39) | SYKJAK2CDK2KDRGSK3B | |
| SCHEMBL6070209 | 0.85 | KDR (0.48) | SYKKCNH2JAK2AURKACDK2 | |
| SCHEMBL6070303 | 0.79 | FLT1 (0.47) | JAK2AURKACDK2CDK9AURKB | |
| SCHEMBL6070198 | 0.78 | KDR (0.39) | SYKCDK2CDK9KDRGSK3B | |
| SCHEMBL6070077 | 0.77 | JAK2 (0.45) | SYKJAK2JAK3EGFRKDR | |
| SCHEMBL6070820 | 0.76 | SYK (0.44) | SYKJAK2CDK2JAK3EGFR | |
| SCHEMBL6069930 | 0.75 | KDR (0.52) | SYKJAK2AURKACDK2CDK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7109204-B2 | controlling signal transduction; anticancer agents, antitumor agents, atherosclerosis, vision defects, antidiabetic agents, antiinflammatory agents | MERCK & CO., INC. (US) | 2006-09-19 | — | — | US | disclosed |